Daniel D Burgess Nabriva Therapeutics PLC (NBRV) insider trading activity

NBRV Quotes by TradingView

Daniel D Burgess is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 10,384 shares of NBRV, which is worth approximately $4,153. The most recent transaction as insider was on Aug 02, 2022, when has been sold 11,341 shares (Ordinary Shares) at a price of $0.19 per share, resulting in proceeds of $2,155. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K
0% 3M change
0% 12M change
Total Value Held $4,153

DANIEL D BURGESS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2022
SELL
Open market or private sale
$2,155 $0.19 p/Share
11,341 Reduced 52.2%
10,384 Ordinary Shares
Aug 02 2021
SELL
Open market or private sale
$1,350 $1.2 p/Share
1,125 Reduced 4.92%
21,725 Ordinary Shares
Jul 28 2021
BUY
Grant, award, or other acquisition
-
17,500 Added 43.37%
22,850 Ordinary Shares

Also insider at

ABUS
Arbutus Biopharma Corp Healthcare
Director
CDTX
Cidara Therapeutics, Inc. Healthcare
Director
DDB

Daniel D Burgess

Director
Fort Washington, PA

Track Institutional and Insider Activities on NBRV

Follow Nabriva Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

News

Receive news related to Nabriva Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBRV